Troikaa Pharmaceuticals
From Wikipedia, the free encyclopedia
 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1983 |
| Founder | Mr. Rajni V. Patel |
| Headquarters | , |
Area served | Worldwide |
Key people |
|
| Products | Pharmaceuticals, Branded and Generic drugs, |
Number of employees | 2300+ (2019) |
| Website | www |
Troikaa Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Ahmedabad city of Gujarat, India.[1] It is a public unlisted company and is classified as company limited by shares.[2][3]
Troikaa Pharmaceuticals limited was established in 1983 in Ahmedabad, Gujarat by Rajni V. Patel, one of the few pharmacy graduates, of the first batch of L. M. College of Pharmacy, Ahmedabad in 1950. Ketan Patel is the current Chairman & Managing Director of the company. According to article, he was named as "India’s pain killer" for inventing world's first painless diclofenac injection, which helps alleviate acute pain and inflammation. Milan R. Patel is Joint Managing Director of the company.
In May 2020, Troikaa received US Patent for one of its products 'Dynapar QPS'.[4]
Operations
Troikaa has three manufacturing facilities in Gujarat and Uttarakhand certified by ISO 9001:2000 and WHO GMP (The World Health Organization for following Good Manufacturing Practices). Company has six marketing divisions & strength of more than 2300 employees. Company has presence in more than 70 countries.[5]
Troikaa secures its innovations related to Novel Drug Delivery systems through Patent co-operation treaty in more than 100 countries of the world.[6][7]